The evidence leans negative2 supporting, 4 against, 1 worth knowing
Supporting
matches consistently growing and profitable, which has beaten the market by +0.51 points over 20 sessions across 117,484 past signals
revenue grew 19% year on year in the quarter ending 30 June 2026
Against
trading 18% below its 200-day average
at 10% of its 52-week range — nearly everyone who bought in the past year is underwater
down 44% over twelve months
net margin has narrowed from 9.5% to 2.3% across four quarters
Worth knowing
RSI at 28 is washed out — historically the better half of this site's measured edge comes from exactly this condition
What would change this read: a close back above 601, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working1
Revenue rose 19.0% year on year, from Rs 211 cr to Rs 251 cr.
+19.0%Rs 211 crRs 251 cr
Needs watching6
Net profit -75.4% year on year, Rs 24 cr to Rs 6 cr.
-75.4%Rs 24 crRs 6 cr
Profit grew slower than revenue, -75.4% against +19.0%.
-75.4%+19.0%
Net margin fell from 11.3% to 2.3%.
11.3%2.3%
Trading 18.0% below its 200-day average.
-18.0%
46% below its 52-week high.
-46%
Down 44.3% over the past year.
-44.3%
Every figure here is computed — from the company’s own filings, or from its own closing prices. Wording of 3 of these 4 filing lines was drafted by a language model, which is given the figures and may not introduce another — any sentence containing a number that did not come from the filings is discarded before it reaches this page.
How it has performed
price return over each window, beside the median NSE stock over the same days
What the scans say today
1 of 47 matched on 10 Sep
PROTEAN matches 1 of the 47 scans today, across 1 different kinds of evidence.
PROTEAN trades at 24× trailing earnings, close to its median of 24× over this window. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
Other filing filings were typically +0.01pt vs the market over the next 5 sessions (n=17,202) · AGM / EGM filings were typically +0.17pt vs the market over the next 5 sessions (n=8,423) · Order win filings were typically -0.10pt vs the market over the next 5 sessions (n=630)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 19% against the same quarter a year earlier
Going against it
profit dropped 75% year on year
net margin narrowed from 9.9% to 2.3%
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
30 Jun · consolidated
251
8
6
1.44
2.3%
Q4 FY26
31 Mar · consolidated
308
36
30
7.49
9.9%
Q3 FY26
31 Dec · consolidated
229
29
22
5.55
9.8%
Q2 FY26
30 Sep · consolidated
250
32
24
5.88
9.5%
Q1 FY26
30 Jun · consolidated
211
32
24
5.88
11.3%
Q4 FY25
31 Mar · consolidated
222
25
20
5.04
9.2%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average-13.0%
Versus 200-day average-18.0%
Below 52-week high-45.6%
Above 52-week low+10.4%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)28.3
Higher closes in last 52 of 5
Six-month return−7.22%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.